T. Korte et al., Hospital readmission after transvenous cardioverter/defibrillator implantation - A single centre study, EUR HEART J, 21(14), 2000, pp. 1186-1191
Aims Hospital readmission after implantation of cardioverter/defibrillators
has a major impact on quality of life and cost-effectiveness in defibrilla
tor patients. Rehospitalization has not been studied in large patient popul
ations with modern transvenous defibrillation systems.
Methods and Results We report on incidence, reasons, time in follow-up dura
tion and predictors of hospital readmission in 180 patients after transveno
us implantation of a cardioverter/defibrillator during a follow-up period o
f 25 +/- 18 months. There were 156 readmissions in 79 patients with a 0.87
readmission rate per patient during the time followed, a 0.46 readmission r
ate per patient-year of follow-up and a 0.38 readmission rate per patient-y
ear of follow-up for cardiac reasons. The majority of readmissions was caus
ed by multiple appropriate shock interventions (26%), battery depletion (19
%) and lead- and device-related complications (14%). The time to first hosp
ital readmission was 12 +/- 9 months for arrhythmia-related and 20 +/- 16 m
onths for other cardiac-related reasons (P<0.05): and could not be predicte
d by clinical variables, respectively. The duration of rehospitalization wa
s 14 +/- 15 days for cardiac-related reasons and 12 +/- 17 days far arrhyth
mia-related reasons. Age >60 years was an independent predictor of rehospit
alization time per patient-year of follow-up for both cardiac-related (P<0.
005) and arrhythmia-related reasons (P<0.05).
Conclusion The rate of hospital readmission per patient-year of follow-up i
s as high as 0.46 after implantation of a modern cardioverter/defibrillator
. Rehospitalization time in such patients is significantly longer in the pa
tient cohort >60 years. The majority of readmissions is caused by multiple
appropriate shock treatments. Further studies are needed to systematically
investigate strategies for the prevention of rehospitalization in modern IC
D therapy. (Eur Heart J 2000; 21: 1186-1191) (C) 2000 The European Society
of Cardiology.